Literature DB >> 24139899

Association between antibodies to multiple infectious and food antigens and new onset schizophrenia among US military personnel.

Yuanzhang Li1, Natalya S Weber, Jared A Fisher, Robert H Yolken, David N Cowan, Rakel A Larsen, David W Niebuhr.   

Abstract

INTRODUCTION: Multiple studies have documented immune activation in many individuals with schizophrenia suggesting that antigens capable of generating a prolonged immune response may be important environmental factors in many cases of this disorder. While existing studies have found single-agent associations of antibodies to food and neurotropic infectious agents with schizophrenia, a simultaneous examination of multiple agents may shed light on agent interactions or possible etiopathogenic pathways.
METHODS: We used traditional regression and novel statistical techniques to examine associations of single and combined infectious and food antigens with schizophrenia. We tested 6106 serum samples from 855 cases and 1165 matched controls.
RESULTS: Higher antibody levels to casein were borderline significant in the prediction of schizophrenia (HR=1.08, p=0.06). Study participants with higher cytomegalovirus (CMV) IgG antibody levels had a reduced risk of developing schizophrenia (HR=0.90; p=0.02). While IgG antibodies to gliadin, Toxoplasma gondii, vaccinia, measles, and human herpesvirus-6 (HHV-6) showed no significant independent associations with schizophrenia, the increase in antibody levels to several combinations of agents, to include casein, measles, CMV, T. gondii and vaccinia, was predictive of an 18-34% increase in the risk of developing schizophrenia.
CONCLUSION: Certain patterns of antibodies, involving some agents, were predictive of developing schizophrenia, with the magnitude of association rising when the level of antibodies increased to two or more agents. A heightened antibody response to a combination of several infectious/food antigens might be an indicator of an altered immune response to antigenic stimuli.
© 2013.

Entities:  

Keywords:  Biomarker; Case–control; Immune response; Psychosis; Sero-epidemiology

Mesh:

Substances:

Year:  2013        PMID: 24139899     DOI: 10.1016/j.schres.2013.10.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

1.  Monocyte activation detected prior to a diagnosis of schizophrenia in the US Military New Onset Psychosis Project (MNOPP).

Authors:  Natalya S Weber; Kristin L Gressitt; David N Cowan; David W Niebuhr; Robert H Yolken; Emily G Severance
Journal:  Schizophr Res       Date:  2018-01-06       Impact factor: 4.939

2.  Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation.

Authors:  Dimitrios Avramopoulos; Brad D Pearce; John McGrath; Paula Wolyniec; Ruihua Wang; Nicole Eckart; Alexandros Hatzimanolis; Fernando S Goes; Gerald Nestadt; Jennifer Mulle; Karen Coneely; Myfanwy Hopkins; Ingo Ruczinski; Robert Yolken; Ann E Pulver
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

3.  Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset.

Authors:  M K Chan; M-O Krebs; D Cox; P C Guest; R H Yolken; H Rahmoune; M Rothermundt; J Steiner; F M Leweke; N J M van Beveren; D W Niebuhr; N S Weber; D N Cowan; P Suarez-Pinilla; B Crespo-Facorro; C Mam-Lam-Fook; J Bourgin; R J Wenstrup; R R Kaldate; J D Cooper; S Bahn
Journal:  Transl Psychiatry       Date:  2015-07-14       Impact factor: 6.222

4.  Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder.

Authors:  Emily G Severance; Kristin L Gressitt; Catherine R Stallings; Emily Katsafanas; Lucy A Schweinfurth; Christina L Savage; Maria B Adamos; Kevin M Sweeney; Andrea E Origoni; Sunil Khushalani; F Markus Leweke; Faith B Dickerson; Robert H Yolken
Journal:  NPJ Schizophr       Date:  2016-05-04

5.  The association between antibodies to neurotropic pathogens and schizophrenia: a case-control study.

Authors:  Lot D de Witte; Hans C van Mierlo; Manja Litjens; Hans C Klein; Sabine Bahn; Ab D Osterhaus
Journal:  NPJ Schizophr       Date:  2015-11-04

Review 6.  Early Senescence and Leukocyte Telomere Shortening in SCHIZOPHRENIA: A Role for Cytomegalovirus Infection?

Authors:  Corona Solana; Diana Pereira; Raquel Tarazona
Journal:  Brain Sci       Date:  2018-10-18

7.  Infectious Causation of Abnormal Host Behavior: Toxoplasma gondii and Its Potential Association With Dopey Fox Syndrome.

Authors:  Gregory Milne; Chelsea Fujimoto; Theodor Bean; Harry J Peters; Martin Hemmington; Charly Taylor; Robert C Fowkes; Henny M Martineau; Clare M Hamilton; Martin Walker; Judy A Mitchell; Elsa Léger; Simon L Priestnall; Joanne P Webster
Journal:  Front Psychiatry       Date:  2020-09-16       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.